Hostname: page-component-586b7cd67f-t7czq Total loading time: 0 Render date: 2024-11-28T05:43:21.375Z Has data issue: false hasContentIssue false

SARS-CoV-2 infection induced thyroid storm and heart failure in an adolescent girl

Part of: Infectious

Published online by Cambridge University Press:  18 October 2021

Bibhuti B. Das*
Affiliation:
Department of Pediatrics, Children’s of Mississippi Heart Center, University of Mississippi Medical Center, Jackson, MS, USA
Divya Shakti
Affiliation:
Department of Pediatrics, Children’s of Mississippi Heart Center, University of Mississippi Medical Center, Jackson, MS, USA
Jyothsna Akam-Venkata
Affiliation:
Department of Pediatrics, Children’s of Mississippi Heart Center, University of Mississippi Medical Center, Jackson, MS, USA
Obiageli Obi
Affiliation:
Department of Pediatrics, Division of Endocrinology, University of Mississippi Medical Center, Jackson, MS, USA
Michael D. Weiland
Affiliation:
Department of Pediatrics, Children’s of Mississippi Heart Center, University of Mississippi Medical Center, Jackson, MS, USA
William Moskowitz
Affiliation:
Department of Pediatrics, Children’s of Mississippi Heart Center, University of Mississippi Medical Center, Jackson, MS, USA
*
Author for correspondence: B. B. Das, MD, FAAP, FACC, Department of Pediatrics, Division of Pediatric Cardiology, University of Mississippi Medical Center, Jackson, MS 39211, USA. Tel: 601-984-5250; Fax: 601-984-5283. E-mail: [email protected]

Abstract

We report a case of thyroid storm precipitated by SARS-CoV-2 infection in an adolescent girl with a history of Graves disease and dilated cardiomyopathy. This case highlights that SARS-CoV-2 infection can potentially trigger a thyrotoxicosis crisis and acute decompensated heart failure in a patient with underlying thyroid disease and myocardial dysfunction even in the absence of multi-system inflammatory syndrome in children. We systematically reviewed the thyrotoxicosis cases with SARS-CoV-2 infection and described its impact on pre-existing dilated cardiomyopathy.

Type
Brief Report
Copyright
© The Author(s), 2021. Published by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

COVID-19 Map. John Hopkins University Coronavirus Resource Center. Retrieved April 26, 2021, fromhttps://coronavirus.jhus.edu/map Google Scholar
Davies, NG, Klepac, P, Liu, Y, Prem, K, Jit, M, Eggo, RM. CMMID COVID-19 working group. Age-dependent effects in the transmission and control of COVID-19 epidemics. Nat Med 2020; 26: 12051211.CrossRefGoogle Scholar
Centers for Disease Control and Prevention. United States COVID-19 Cases and Deaths by State. Updated August 19, 2020. Retrieved April 13, 2021, from https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/cases-in-us.html Google Scholar
Alsaied, T, Tremouulet, AH, Burns, JC, et al. Review of cardiac involvement in multisystem inflammatory syndrome in children. Circulation 2021; 143: 7888.CrossRefGoogle ScholarPubMed
Friedrich, MG, Sechtem, U, Schulz-Menger, J, et al. Cardiovascular magnetic resonance in myocarditis: a JACC white paper. J Am Coll Cardiol 2009; 53: 14751487.CrossRefGoogle ScholarPubMed
Pastor, S, Molina, Sr. A, Celis, De E. Thyrotoxicocrisis and COVID-19 infection: an extraordinary case and literature review. Cureus 2020; 12: e11305.Google ScholarPubMed
Brancatella, A, Ricci, D, Viola, N, Sgro, D, Santini, F, Latrofa, F. Subacute thyroiditis after SARS-CoV-2 infection. J Clin Endocrinol Metab 2020; 105: 23672370.CrossRefGoogle ScholarPubMed
CDC. Multisystem inflammatory syndrome in children (MIS-C) associated with coronavirus disease 2019 (COVID-19). Retrieved March 30, 2021, from https://www.cdc.gov/coronavirus/2019-ncov/daily-life-coping/children/mis-c.html Google Scholar
The European Society of Cardiology.ESC Guidance for the diagnosis and management of CV disease during the COVID-19 pandemic. Retrieved March 30, 2021, from https://www.escardio.org/Education/VOVID-19-and-Cardiology/ESC-COVID-19-Guidance Google Scholar
Liu, F, Long, X, Zhang, B, Zhang, W, Chen, X, Zhang, Z. ACE2 expression in pancreas may cause pancreatic damage after SARS-CoV-2 infection. Clin Gastroenterol Hepatol 2020; 22: 21282130.CrossRefGoogle Scholar
Li, W, Moore, MJ, Vasilieva, N, et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 2003; 426: 450454.CrossRefGoogle ScholarPubMed
Li, MY, Li, L, Zhang, Y, Wang, XS. Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Infect Dis Poverty 2020; 9: 45.CrossRefGoogle Scholar
Kristoffersen, AW, Knudsen, PK, Moller, T. SARS-CoV-2 in an infant with severe dilated cardiomyopathy. Cardiol Young 2021; 31: 485487.CrossRefGoogle Scholar
Puntmann, VO, Carerj, ML, Wieters, I, et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiol 2020; 5: 12651273.CrossRefGoogle Scholar
Lindner, D, Fitzek, A, Brauninger, H, et al. Association of cardiac infection with SARS-CoV-2 in confirmed COVID-19 autopsy cases. JAMA Cardiol 2020; 5: 12811285.CrossRefGoogle ScholarPubMed